BNA's Pharmaceutical Patent Laws Conference
Event | 11.12.08, 12:00 AM UTC - 12:00 AM UTC
A fast-paced conference on the latest developments and changes in pharmaceutical patent law—get insights from key government regulators, industry insiders, and leading legal experts.
Melissa Hayworth is one of the co-chairs and is a panelist on "Trends in Declaratory Judgment Actions: Where Are Courts Headed?"
For more information, please visit these areas: Intellectual Property Litigation, Intellectual Property
Insights
Event | 12.04.25
ACI 30th Annual Conference on Drug & Medical Device Litigation
Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.
Event | 12.03.25 - 12.04.25
Caroline Brown to Speak at ACI New York Forum on Economic Sanctions
Event | 11.04.25
